title: Counterpoint: A Diabetes Outcome Progression Trial (ADOPT): good for sulfonylureas?
authors.forename: Ebaa
authors.initials: E
authors.lastname: Al-Ozairi
authors.forename: Latika
authors.initials: L
authors.lastname: Sibal
authors.forename: Philip
authors.initials: P
authors.lastname: Home
mesh_terms: D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism; D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D015203:Reproducibility of Results; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*
chemical_list: D001786:Blood Glucose; D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds